Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Hernaez
James P Hamilton

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Clinical Liver Disease|May 2, 2019
Unexplained ascitesRuben Hernaez, James P Hamilton
Gut|May 13, 2021
Reply to: "Acute-on-chronic liver failure in East-Asia: an underestimated issue with limited data"Adrià Juanola, Gabriel Mezzano, James P Hamilton, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 17, 2021
Proposing a Framework to Assess the Methodological Quality of Prognostic ModelsRuben Hernaez
Gastroenterologia Y Hepatologia|November 19, 2011
Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative reviewRuben Hernaez
Gut|April 16, 2015
Reliability and agreement studies: a guide for clinical investigatorsRuben Hernaez
Clinical Liver Disease|May 4, 2022
Leveraging Telemedicine for Quality AssessmentRuben Hernaez, Fasiha Kanwal
Gut|March 31, 2021
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinomaRuben Hernaez, Robert Thimme
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 18, 2024
Breathing new life to posttransplant survival modelsAvegail Flores, Ruben Hernaez
Gut|March 18, 2024
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity?Samy Suissa, Ruben Hernaez
Gut|September 19, 2024
High-risk varices in patients with Child-Pugh-Turcotte B and C: consider band ligation with carvedilol for preventing first variceal bleeding, especially in patients with MASLD-associated cirrhosisAlexander Zipprich, Ruben Hernaez
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Clinical Liver Disease|May 2, 2019
Unexplained ascitesRuben Hernaez, James P Hamilton
Gut|May 13, 2021
Reply to: "Acute-on-chronic liver failure in East-Asia: an underestimated issue with limited data"Adrià Juanola, Gabriel Mezzano, James P Hamilton, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 17, 2021
Proposing a Framework to Assess the Methodological Quality of Prognostic ModelsRuben Hernaez
Gastroenterologia Y Hepatologia|November 19, 2011
Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative reviewRuben Hernaez
Gut|April 16, 2015
Reliability and agreement studies: a guide for clinical investigatorsRuben Hernaez
Clinical Liver Disease|May 4, 2022
Leveraging Telemedicine for Quality AssessmentRuben Hernaez, Fasiha Kanwal
Gut|March 31, 2021
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinomaRuben Hernaez, Robert Thimme
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 18, 2024
Breathing new life to posttransplant survival modelsAvegail Flores, Ruben Hernaez
Gut|March 18, 2024
Glucagon-like peptide-1 receptor agonists to treat chronic liver disease: real-world evidence or ambiguity?Samy Suissa, Ruben Hernaez
Gut|September 19, 2024
High-risk varices in patients with Child-Pugh-Turcotte B and C: consider band ligation with carvedilol for preventing first variceal bleeding, especially in patients with MASLD-associated cirrhosisAlexander Zipprich, Ruben Hernaez
Pageof 22